Press Releases iTeos Therapeutics, Inc.

Equities

ITOS

US46565G1040

Real-time Estimate Cboe BZX Other stock markets 12:06:23 2024-04-29 pm EDT			5-day change	1st Jan Change
10.83 ^USD	+0.28%		+0.06%	-1.40%

Mar. 13	Top Premarket Decliners	MT
Mar. 12	JPMorgan Adjusts Price Target on iTeos Therapeutics to $27 From $29, Maintains Overweight Rating	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ITeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024	Apr. 07	AQ
ITeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024	Apr. 07	GL
ITeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates	Mar. 06	GL
ITeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors	Mar. 06	GL
ITeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates	Mar. 06	AQ
ITeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors	Mar. 06	AQ
ITeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024	Mar. 05	GL
ITeos to Participate in Upcoming Investor Conferences	Mar. 01	GL
ITeos Announces 2024 Strategic Priorities and Anticipated Milestones	Jan. 08	GL
ITeos Announces 2024 Strategic Priorities and Anticipated Milestones	Jan. 08	AQ
NiKang Therapeutics Appoints Joanne Lager, M.D., as Chief Medical Officer	Jan. 05	AQ
ITeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	AQ
ITeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	GL
ITeos to Present at the Piper Sandler 35th Annual Healthcare Conference	Nov. 21	GL
ITeos to Present at the Piper Sandler 35th Annual Healthcare Conference	Nov. 21	AQ
ITeos Reports Third Quarter 2023 Financial Results and Provides Business Updates	Nov. 07	GL
ITeos to Participate in Upcoming Investor Conferences	23-09-06	GL
ITeos to Participate in Upcoming Investor Conferences	23-09-06	AQ
ITeos Reports Second Quarter 2023 Financial Results and Provides Business Updates	23-08-08	GL
ITeos Reports Second Quarter 2023 Financial Results and Provides Business Updates	23-08-08	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases iTeos Therapeutics, Inc.

Equities

ITOS

US46565G1040

Press Releases

Filters